Business Context and Reporting Period
Company: Olenox Industries Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 6, 2026
Principal Executive Offices: Conroe, TX
Trading Symbol: SGBX (Nasdaq)
This filing reports the appointment of two new directors to the Company's Board of Directors to fill vacancies.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
Board Composition: On February 6, 2026, the Board appointed Erik Blum and Adam Falkoff as directors. They will serve until the 2025 Annual Meeting of Shareholders and until their successors are elected.
- Erik Blum: CEO of Fynntechnical Innovations Inc. with over 30 years of experience in debt, corporate finance, and company management, including corporate turnarounds.
- Adam Falkoff: President of CapitalKeys with over 20 years of experience in public policy, international relations, and business development, including prior roles at Microsoft and Amazon.
Compensatory Arrangements and Outlook
Both directors are non-employee directors participating in the Company's existing compensation program. In connection with their February 2026 appointment, they will receive pro-rata portions of the following:
- Cash Retainer: $40,000 annually, paid in quarterly installments.
- Committee Chair Retainer: $10,000 annually per committee chair position held.
- Equity Grant: Restricted stock units (RSUs) with a grant-date value of approximately $50,000, vesting quarterly over two years subject to continued service.
The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of risks and contingencies beyond standard disclosures regarding the absence of family relationships or related-party transactions.
Investor Verification Checklist
- Verify the exact vesting schedule and grant date value of the RSUs issued to Messrs. Blum and Falkoff in subsequent filings.
- Confirm the date of the 2025 Annual Meeting of Shareholders to determine the exact tenure of the new directors.
- Review the Company's most recent 10-K or 10-Q for current financial health, as this 8-K contains no financial metrics.
- Monitor for any changes in committee assignments for the new directors, which would trigger additional cash retainers.